English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 9 October 2020, 21:00 HKT/SGT
Share:
    

Source: Woori BMO Group
Woori BMO Group Reports on Clover Health as They Go Public in $3.7 Billion SPAC Deal

TORONTO, ONTARIO , Oct 9, 2020 - (ACN Newswire) - Woori BMO Group has today commented on Clover Health, the insurance start-up backed by Alphabet Inc. and Sequoia, as it agrees to go public through a merger with a special purpose acquisition company created by Palo Alto-based venture capitalists, Social Capital Hedosophia Holdings Corp. III.

Christian Harper, Director of EMEA Wealth Management at Woori BMO Group, reported, "The deal gives Clover Health a company valuation of $3.7 billion, raising $1.2 billion in proceeds. Of this amount, $828 million will come from the SPAC company, Social Capital Hedosophia Holdings Corp. III, with a further $400 million coming from private investors."

The founder and chief executive officer of Social Capital, Chamath Palihapitiya, said he would personally invest $100 million into the combined company.

Palihapitiya said in an investor call on Tuesday, "I have known Vivek (CEO of Clover) for almost ten years. As an investor, the most basic thing you need to know is this is the ultimate healthcare disruptor. We are going to fortify this balance sheet, so Clover has the ability to aggressively build and expand all throughout America."

Clover Health provides Medicare Advantage plans in 34 counties across seven states, with its biggest market being New Jersey. Its plans received a three out of five Medicare star rating for 2020.

Unlike many other health insurance start-ups which promote narrow-network plans to lower costs, Clover Health has structured most of its plans as PPO networks. It advocates a software tool it has developed for primary care physicians as a way of reducing variability and healthcare expenses.

The company has also faced some challenges along the way. In 2018, Clover lost its former CTO and COO in quick succession. It later hired Andrew Toy, who sold his previous start-up to Google, as its CTO and president. Last year, after raising $500 million, the company cut a quarter of its workers, which it described as a restructuring to shift some of its resources to become experts in the Medicare Advantage market.

Woori BMO Group's Head of Institutional Equity, Andrew Williams, reported, "Clover Health generated $462 million in revenue last year, an increase from $290 million in 2018. The company did, however, suffer a net loss of $60.57 million."

Williams added, "Looking toward 2021, the company is projecting revenues of $880 million and 273,000 members. That is over four times the amount of its current memberships which is around 57,000."

Clover will use the funds to boost the start-up's growth, with the company planning to expand into 74 more counties and an eighth state next year.

About Woori BMO Group

Woori BMO Group is a full-service wealth management company providing both corporate institutions and private clients a tailored financial advisory service from its retail office in Toronto, Canada.

Media Contact

Mr. Shinsato Masao
Chief Economist
Telephone: +1-647-946-8880
Email: shinsato.masao@wbginternational.com
25F Exchange Tower
130 King Street West
Toronto, ON, Canada
M5X 1E3

Related Links
Woori BMO Group https://www.wbginternational.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/65615

Topic: Press release summary
Source: Woori BMO Group

Sectors: Daily Finance, Daily News, Healthcare & Pharm, Funds & Equities, Banking & Insurance, PE, VC & Alternatives, Local Biz
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Woori BMO Group Related News
Oct 16, 2020 03:00 HKT/SGT
Woori BMO Group Comments on Finance of America Set for IPO
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575